BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22019230)

  • 41. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Zibetti M; Merola A; Rizzi L; Ricchi V; Angrisano S; Azzaro C; Artusi CA; Arduino N; Marchisio A; Lanotte M; Rizzone M; Lopiano L
    Mov Disord; 2011 Nov; 26(13):2327-34. PubMed ID: 22012750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropsychological effects of bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Bordini BJ; Garg A; Gallagher CL; Bell B; Garell PC
    Stereotact Funct Neurosurg; 2007; 85(2-3):113-20. PubMed ID: 17228177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between subthalamic nucleus deep brain stimulation and weight gain: Results of a case-control study.
    Strowd RE; Herco M; Passmore-Griffin L; Avery B; Haq I; Tatter SB; Tate J; Siddiqui MS
    Clin Neurol Neurosurg; 2016 Jan; 140():38-42. PubMed ID: 26619034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.
    Moreau C; Defebvre L; Destée A; Bleuse S; Clement F; Blatt JL; Krystkowiak P; Devos D
    Neurology; 2008 Jul; 71(2):80-4. PubMed ID: 18420482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson's disease.
    Davis JT; Lyons KE; Pahwa R
    Clin Neurol Neurosurg; 2006 Jul; 108(5):461-4. PubMed ID: 16139421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
    Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
    J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation.
    Accolla E; Caputo E; Cogiamanian F; Tamma F; Mrakic-Sposta S; Marceglia S; Egidi M; Rampini P; Locatelli M; Priori A
    Mov Disord; 2007 Jun; 22(8):1150-6. PubMed ID: 17469208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.
    Aono M; Iga J; Ueno S; Agawa M; Tsuda T; Ohmori T
    J Clin Neurosci; 2014 Sep; 21(9):1595-8. PubMed ID: 24794694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of ghrelin, neuropeptide Y and leptin peptides in weight gain after deep brain stimulation for Parkinson's disease.
    Markaki E; Ellul J; Kefalopoulou Z; Trachani E; Theodoropoulou A; Kyriazopoulou V; Constantoyannis C
    Stereotact Funct Neurosurg; 2012; 90(2):104-12. PubMed ID: 22398667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term evaluation of gait initiation in six Parkinson's disease patients with bilateral subthalamic stimulation.
    Muniz AM; Nadal J; Lyons KE; Pahwa R; Liu W
    Gait Posture; 2012 Mar; 35(3):452-7. PubMed ID: 22154114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An 8-Year Follow-up on the Effect of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease.
    Jung YJ; Kim HJ; Jeon BS; Park H; Lee WW; Paek SH
    JAMA Neurol; 2015 May; 72(5):504-10. PubMed ID: 25799451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.
    Constantinescu R; Eriksson B; Jansson Y; Johnels B; Holmberg B; Gudmundsdottir T; Renck A; Berglund P; Bergquist F
    Clin Neurol Neurosurg; 2017 Mar; 154():43-48. PubMed ID: 28113102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive effects of subthalamic nucleus stimulation in Parkinson's disease: a controlled study.
    Sáez-Zea C; Escamilla-Sevilla F; Katati MJ; Mínguez-Castellanos A
    Eur Neurol; 2012; 68(6):361-6. PubMed ID: 23095782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of subthalamic nucleus deep brain stimulation on the autonomic nervous system in Parkinson's disease patients assessed by spectral analyses of R-R interval variability and blood pressure variability.
    Sumi K; Katayama Y; Otaka T; Obuchi T; Kano T; Kobayashi K; Oshima H; Fukaya C; Yamamoto T; Ogawa Y; Iwasaki K
    Stereotact Funct Neurosurg; 2012; 90(4):248-54. PubMed ID: 22699844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Weight gain following subthalamic nucleus deep brain stimulation: a PET study.
    Sauleau P; Le Jeune F; Drapier S; Houvenaghel JF; Dondaine T; Haegelen C; Lalys F; Robert G; Drapier D; Vérin M
    Mov Disord; 2014 Dec; 29(14):1781-7. PubMed ID: 25382049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease: five year follow-up at a Portuguese center.
    Monteiro A; Andrade C; Rosas MJ; Linhares P; Massano J; Vaz R; Garrett C
    Rev Neurol; 2014 May; 58(10):433-9. PubMed ID: 24819939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.